IMPORTANCE Intracranial atherosclerotic disease (ICAD) is an important cause of stroke; however, little is known about racial differences in ICAD prevalence and its risk factors.
S trokes are reported more frequently in black than white individuals. 1 Intracranial atherosclerotic disease (ICAD)
is a major contributor to ischemic stroke, 2 but it remains to be established if ICAD is also more prevalent in black individuals in the general population. Our current understanding of ICAD distribution and its risk factors is based on stenosis measurements primarily from symptomatic cohorts [3] [4] [5] [6] ;however, as many as 75% of patients who develop strokes have not had prior strokes. 7 A large study of intracranial calcifications in internal carotid arteries in white European descendants by computed tomography reported more than 80% prevalence 8 ; however, this likely overestimates ICAD because Möncke-berg arteriosclerosis accounts for calcifications here. 9 Furthermore, previous studies [10] [11] [12] identified ICAD as lumen narrowing of intracranial arteries. Lumen narrowing, however, is a poor indicator of plaque burden when vessels accommodate plaque formation by compensatory dilatation (remodeling). 13 The recent development of 3-dimensional (3-D) vessel wall magnetic resonance imaging (MRI) has made possible the identification and characterization of ICAD, providing highly reliable intracranial vessel wall measurements. 14, 15 Previous studies also involved older adults in whom traditional risk factors (eg, blood pressure, cholesterol level) may have been altered by medical treatment or lifestyle modifications, but lacked information on midlife risk factor levels that may be more relevant to atherosclerotic burden later in life. 8, 11 Identifying these midlife risk factors and understanding their implications based on race and sex is an important step in preventive treatment strategies, recognizing that the effect of these strategies may not be perceived for decades. The objective of this study was to determine racial differences in ICAD prevalence and the risk factors (both midlife and concurrent) associated with its development in a large community-based study, the Atherosclerosis Risk in Communities Study (ARIC).
Methods

Study Population
The ARIC study is a community-based, prospective investigation of 15 792 black and white participants recruited in middle age (45-64 years) from 4 US communities (Forsyth County, North Carolina; Jackson, Mississippi; suburban Minneapolis, Minnesota; and Washington County, Maryland). 16 The baseline examination (visit 1) took place from 1987 to 1989, with 4 subsequent visits.
Of the 6538 participants who attended ARIC visit 5 (from October 18, 2011, to December 30, 2013), 1980 were selected for brain MRI using a probability sampling mechanism with oversampling of participants with cognitive impairment and those who had a prior brain MRI. A total of 1752 black and white participants (mean [SD] 
Assessment of Intracranial Atherosclerosis
The MRI protocol has been previously described.
14 Briefly, all MRI scans were performed on 3.0T Siemens scanners. Highresolution vascular sequences were acquired at the end of a standardized brain MRI protocol and consisted of a 3-D timeof-flight magnetic resonance angiography (MRA) and 3-D highisotropic resolution black blood MRI with acquired resolutions of 0.50 × 0.50 × 0.55 mm 3 and 0.50 × 0.50 × 0.50 mm 3 , respectively. The MRI images were analyzed by 7 certified readers at the MRI reading center without knowledge of participant characteristics.
An atherosclerotic plaque was defined as wall thickening on reconstructed black blood MRI images with or without luminal stenosis on MRA. 15 Vascular territories were categorized as right and left intracranial internal carotid artery (cavernous and supraclinoid segments), right and left middle cerebral artery (M1-M3 segments), right and left posterior cerebral artery (P1-P3 segments), right and left anterior cerebral artery (A1-A3 segments), basilar artery, and right and left vertebral artery (V4 segment). All plaques were recorded for each vascular territory. The degree of stenosis was measured according to the criteria established in the Warfarin-Aspirin Symptomatic Intracranial Disease trial, 17 and categorized as no detectable stenosis, less than 50%, 51% to 70%, 71% to 99%, and occlusion. The area and normalized wall index (NWI) (wall area / outer wall area) were measured for the most stenotic plaque identified in each territory. The NWI uses wall area to standardize measures of plaque size and enables comparison of plaques in vessel segments of varying size. Reliability estimates for plaque detection and measurements were good to excellent as previously reported. 15 
Assessment of Traditional Cardiovascular Risk Factors
Cardiovascular risk factors measured at visits 1 and 5 were used in this study and included smoking history (current, past, or
Key Points
Question Are there racial differences in the prevalence of and risk factors for intracranial atherosclerotic disease?
Findings In this Atherosclerosis Risk in Communities cohort study of 1752 elderly adults, black men had the highest prevalence of intracranial atherosclerotic disease and the highest frequency of multiple plaques. Midlife smoking and diabetes were associated with late-life intracranial atherosclerotic disease in black individuals only, whereas midlife hypertension and hyperlipidemia were associated with late-life intracranial atherosclerotic disease in both races.
Meaning Racial differences in intracranial atherosclerotic disease prevalence may help to explain stroke rates in the United States, and differences in intracranial atherosclerotic disease risk factors could offer insight into preventive risk-factor management strategies. 
Statistical Analysis
Data analysis was performed from October 18, 2011, to May 13, 2015. All analyses were performed using Stata, version 12.1 (Stata Inc). Stata svy commands with sampling weights were used to account for oversampling of participants with cognitive impairment and provide estimates referable to the overall ARIC population from which participants were sampled (ARIC visit 5, n = 6538). In addition, we used inverse probability of attrition weighting to adjust for potential selection bias due to the underrepresentation of individuals who died or were lost to follow-up between ARIC visits 1 and 5 18 (eMethods in the Supplement). The prevalence of ICAD was estimated in the overall ARIC population and stratified by sex and race. Demographic and risk factor variables were compared between races using unpaired, 2-tailed t tests for continuous variables and χ 2 tests for categorical variables.
ICAD prevalence by age was estimated from Poisson regression models using restricted cubic splines with knots at the 10th, 50th, and 90th percentiles of the age distribution and stratified by sex and race. Prevalence ratios (PRs) for plaque presence for visit 1 and visit 5 risk factors were calculated separately using multivariable Poisson regression. A full model was then established including all risk factors from both visits. We also used Poisson regression models to estimate marginally adjusted prevalence of ICAD as a function of risk factor levels after controlling for use of antihypertensive, cholesterollowering, and antidiabetic medications. All models were adjusted for age, sex, and race, and repeated with race stratification. Negative binomial regression was used to estimate the ratio of the number of plaques per participant by risk factor levels (combined risk factors from both visits). In addition, multivariable linear regression was used to estimate mean differences in maximum NWI within a participant (a marker of plaque burden) as a function of risk factor levels (combined risk factors from both visits). Racial differences in associations between risk factors and ICAD were estimated using interaction terms between race and each risk factor. P <.05was considered significant.
Results
Participant Characteristics
Most black participants were younger than white participants and were more likely to have hypertension and diabetes but less likely to have hyperlipidemia at both midlife and late-life visits ( Table 1) . A higher prevalence of cardiovascular disease risk factors was observed in late life compared with midlife in both the white and black groups.
Racial Difference in ICAD Prevalence
Of the 1752 participants, 637 (36.4%) had ICAD with at least 1 intracranial plaque, and 69 of 637 individuals (10.8%) had intracranial plaques without detectable stenosis. The distribution of plaques across intracranial vascular territories is reported in eTable 1 in the Supplement. ICAD prevalence in the ARIC cohort at visit 5 was 34.4% and was highest for black men (50.9% for black men vs 35.9% for black women, 35.5% for white men, and 30.2% for white women, P < .001). Black men also had the highest frequency of multiple plaques (22.4% of black men had >3 plaques vs 12.1% for black women, 10.7% for white men, and 8.7% for white women; P <.01)( Figure 1 ). The prevalence of ICAD increased with age for each group, reaching 50% in black men before age 68 years, white men by 84 years, and white women by 88 years ( Figure 2 ; eFigure 1 in the Supplement). The percentage of participants older than 77 years was 38%, 47%, 53%, and 56% for black women, white women, black men, and white men, respectively. Black women did not reach 50% even by 90 years. A rise in prevalence began at approximately 77 years for all groups except black women, who showed no significant change above this age (Figure 2 ; eFigure 1 in the Supplement). After excluding participants with a history of stroke (n = 60), the weighted ICAD prevalence was 33.3% (49.6% for black men, 34.8% for black women, 34.6% for white men, and 29.3% for white women, P < .001).
Associations of Cardiovascular Disease Risk Factors With ICAD
Midlife (visit 1) hypertension and hyperlipidemia were independently associated with plaque presence, after controlling for age, sex, race, and other midlife cardiovascular risk factors ( Table 2) . No associations were identified for visit 5 risk factors using a comparable model. In a combined model including all risk factors from both visits, midlife hypertension and hyperlipidemia were associated with a 29% (PR, 1.29; 95% CI, 1.08-1.55) and 18% (PR, 1.18; 95% CI, 0.98-1.42), respectively, increased prevalence of having ICAD by visit 5 irrespective of hypertensive or hyperlipidemic status at visit 5 (Table 3) , with no evidence for differences in effect between black and white participants (Table 3) . Midlife smoking and diabetes were associated with 102% (PR, 2.02; 95% CI, 1.12-3.63) and 57% (PR, 1.57; 95% CI, 1.13-2.19), respectively, increased prevalence of ICAD by visit 5 in black participants irrespective of smoking or diabetic status at visit 5, but associations were not present for white participants (Table 3) .
When risk factors were analyzed as continuous variables, the prevalence of ICAD was significantly increased with con-current (visit 5) measures of systolic blood pressure as well as fasting glucose and total cholesterol levels, and decreased with high-density lipoprotein cholesterol levels after adjusting for medication use (eFigure 2 in the Supplement). Associations were strongest in black men.
Midlife hypertension and hyperlipidemia were associated with a 39% (ratio 1.39; 95% CI, 1.07-1.80) and a 33% (ratio, 1.33; 95% CI, 1.04-1.71), respectively, increase in plaque number by visit 5 irrespective of risk status at visit 5 (eTable 2intheSupplement). Midlife hypertension was also associated with a higher mean maximum NWI (mean difference comparing hypertensive with nonhypertensive status, 1.11; 95% CI, 0.21-2.01) irrespective of hypertensive status at visit 5 (eTable 3 in the Supplement). Midlife smoking was associated with a 57% (ratio, 1.57; 95% CI, 1.06-2.33) increase in plaque number in black participants irrespective of visit 5 smoking status, but no association was seen in white participants. Midlife smoking, diabetes, and hyperlipidemia were not associated with plaque size by visit 5 in black or white individuals. We repeated the regression models after excluding participants with a history of stroke and noted no change in the above associations.
Discussion
To our knowledge, this is the first study to report racial differences in prevalence and risk factors for ICAD in a large, US community-based population. Black participants had a higher ICAD prevalence than white participants, and we also observed racial differences in risk factors for ICAD. Midlife smoking and diabetes were strongly associated ). We found that as many as 10.8% of our participants had ICAD without detectable stenosis based on black blood MRI and these cases would have eluded MRA detection, limiting analyses based on stenosis alone. 
Number of plaques
Prevalence was weighted to the Atherosclerosis Risk in Communities study cohort at visit 5. The intracranial plaque prevalence for black men was higher compared with other race and sex groups (P < .01). was 38%, 47%, 53%, and 56% for black women, white women, black men, and white men, respectively. MRI indicates magnetic resonance imaging.
Racial Differences in Prevalence of and Risk for Intracranial Atherosclerosis
Original Figure 2 ) may also explain the crossover in stroke mortality rates reported at 85 years, when mortality rates in white individuals begin to exceed rates in black individuals.
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Racial differences were also observed with risk factors for ICAD, most notably, the associations between ICAD with midlife smoking and diabetes seen in black but not white participants. The mechanisms for racial differences in ICAD prevalence and associated risk factors could be complex and might include genetic and ecosocial factors. 24, 25 Furthermore, at midlife, black participants had a higher frequency of current smokers and a lower frequency of former smokers, which might have influenced associations with late-life ICAD in the black but not white cohort. The weak associations between ICAD and late-life risk factor measurements could partly stem from reverse causation 30 due to changes in lifestyle (eg, smoking cessation), the high a Associations between plaque presence and visit 1 and visit 5 factors were evaluated separately using Poisson regression models. Inverse probability of attrition weighting was incorporated with study visit 5 sampling weights applied.
b Age is based on the time of the visit 5 magnetic resonance imaging examination.
c Strongest association. e Dropped from the model (only 3 black participants with history of coronary heart disease).
prevalence of some risk factors in late life (eg, hypertension), or the definitions used to establish the presence of risk factors, which include treatment as part of the definition. When late-life risk factors were analyzed as continuous variables, increasing systolic blood pressure as well as fasting glucose and total cholesterol levels, and decreasing high-density lipoprotein cholesterol levels were associated with increased ICAD presence, suggesting that ICAD depends on risk factor degree rather than exceeding a threshold. The major strengths of our study include the use of advanced 3-D black blood MRI to reliably identify and quantify ICAD in a large, nationally representative sample, with access to a wide range of vascular risk factors measured over 20 years. This new MRI technique allowed us to identify ICAD even in the absence of luminal narrowing. The large black population enabled discriminating racial differences in ICAD prevalence and its associated risk factors.
Limitations
Some limitations, however, need to be considered in the interpretation of our findings. Our precision for estimating ICAD prevalence for black women older than 77 years was lower than for the other groups (Figure 2 ) so we primarily focused on black and white racial differences. Although we used inverse probability of attrition weighting to compensate for the effect of attrition from death or dropout since ARIC visit 1, attrition may have been disproportionate between the races since more black participants died before visit 5. 18 We cannot discard residual biases, particularly for race comparisons at advanced age. Treatment decisions may also have affected risk factor associations. For example, participants with better risk factor management (eg, cholesterol lowering or blood pressure control) since midlife may have fewer or smaller ICAD lesions in late life. These patterns could dilute associations between visit 5 risk factors and ICAD. In addition, future studies should include other racial groups (eg, Hispanic or Asian) to better reflect an urban population. Finally, the lack of ICAD measures at the baseline visit prohibits an investigation of ICAD progression, which may have different risk factors. Longitudinal studies of ICAD would be needed to estimate these associations.
Conclusions
In this community-based population study of black and white elderly adults, the prevalence of ICAD was higher in the blacks than the white participants, with the highest prevalence and highest frequency of multiple lesions seen in black men. Midlife smoking and diabetes were associated with late-life ICAD presence in black but not white individuals, whereas both races demonstrated associations between midlife hypertension and hyperlipidemia with ICAD presence and intracranial plaque number, and hypertension further contributed to intracranial plaque size. These racial differences may contribute to racial differences in stroke rates in the United States, providing insight into stroke risk and potential strategies for risk reduction.
eMethods. Statistical Methods Used for Adjusting for Selection and Survival Bias in ARIC Studies
With respect to bias, probably the most important source of bias that may affect estimates in our study is agerelated selection bias (a combination of survival and non-response bias). A major advantage of ARIC (as compared to de novo surveys in elderly participants), is that we can track the ARIC sample for over 25 years, and we can use estimates that take into account cohort attrition. In addition, our study was based in the ARIC Neurocognitive Study (NCS), an ancillary study conducted in ARIC Visit 5 to obtain 2,000 brain MRIs from study participants. In the ARIC NCS study, participants with evidence of cognitive impairment were oversampled as it was thought that these participants would provide more information for neurocognitive outcomes (the primary objective of the ARIC NCS study). In our analysis, we used a combination of survey sampling methods and inverse probability attrition weighting (IPAW) to take these factors into account, as follows:
1) For the main analysis, we used survey sampling methods to obtain prevalence estimates that could be applicable to ARIC Visit 5 (Stage 1) participants. Of 10,749 original cohort members deemed alive at the start of visit, 713 (6.6%) died during the 15 month recruitment period without having visit 5, leaving 10,036 who were either examined or not examined but alive through August 2013. Of these, 6,538 (age range=66 to 90 years) took part in visit 5 (5,918 full clinic exams, 228 abbreviated clinic exams, 392 home or care facility exams) (https://www2.cscc.unc.edu/aric/Visit_5_NCS_Stage_1_Cohort_Description). From this initial sample, the objective was to obtain 2,000 brain MRIs (ARIC NCS) as follows: Cohort Visit 5 (Stage 1) participants were selected under a probability sampling plan designed to oversample for participants with evidence of cognitive impairment ("atypical"). In brief, 100% of atypical participants (low MMSE score, or low Z-score on any of 5 cognitive domains and definite cognitive decline) as well as 100% of ARIC Brain MRI participants were invited to Stage 2 (the ARIC Brain MRI study was an ancillary study conducted at Visit 3 in the Jackson and Forsyth County sites that performed brain MRIs in 1,927 Visit 3 participants). A random sample of the remaining participants, with selection probabilities varied by field center and age group (<80, ≥80 years), was also invited (Stage 2). Participants were invited to Stage 3 if they were selected to Stage 2, had no contraindications to MRI and (initially) if they attended a clinic visit. This was later revised so that participants completing home visits were invited to Stage 3 as well, but only 10 such participants completed a Stage 3 exam. The goal was to achieve a sample size of 2,000 Stage 3 participants. Selection probabilities were adjusted periodically to achieve that goal; updated selection probabilities were then applied retrospectively so that all participants within a given stratum had an equal probability of selection, regardless of timing of the Stage 1 visit. These weights and the associated survey sampling methods were developed by the ARIC study and have been applied to multiple ARIC NCS MRI analyses. The main analyses of the paper are thus weighted to represent the ARIC Visit 5 (Stage 1) sample.
2) As sensitivity analyses, we further applied a second type of weights also developed by the ARIC study and applied in multiple papers (i.e., Gottesman, JAMA Neuro 2014, 71 (10) ). This second set of weights was developed for use in IPAW to address selection bias in Visit 5 due to underrepresentation of individuals who died or were lost-to-follow-up between ARIC Visit 1 and Visit 5 (these weights were also estimated as inverse estimated probabilities of selection). These set of weights are applied to Visit 5 analyses and provide the prevalence of ICAD in the counterfactual situation that all participants in Visit 1 had remained alive and attended Visit 5 exam. Based on multivariable linear regression adjusted for CVD risk factors and race. Age is based on the time of the Visit 5 MRI exam. Bold indicates strongest associations. *, significant difference between blacks and whites including all main terms and interactions between race and each risk factor. †, dropped from the model (only 3 blacks with history of coronary heart disease). CVD, cardiovascular disease; ICAD, intracranial atherosclerotic disease; CI, confidence interval.
